4.4 Article

Amphotericin B liposomal formulation: applicable preparation methods, challenges, and tips

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Comparison of three synthetic transferrin mimetic small peptides to promote the blood-brain barrier penetration of vincristine liposomes for improved glioma targeted therapy

Solmaz Mojarad-Jabali et al.

Summary: The development of a modified liposomal formulation has shown promising results in facilitating brain targeted delivery and selective accumulation within glioma cells. Among the studied targeting ligands, T7-modified liposomes demonstrated superior BBB penetration, brain distribution, and increased accumulation in glioma cells, leading to improved anti-glioma outcomes through targeted cytotoxicity and apoptosis. These results suggest that T7-modified liposomes could serve as a potential platform for effective brain targeted delivery and glioma therapy in clinical settings.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)

Article Pharmacology & Pharmacy

Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes

Guilherme S. Ramos et al.

Summary: This study developed a formulation of PEGylated liposomal AmB and compared its efficacy to AmBisome (R) in a murine model of cutaneous leishmaniasis (CL). The results showed that the PEGylated formulation significantly reduced lesion growth and parasite load in the treatment of CL, both through parenteral and oral routes.

PHARMACEUTICS (2022)

Article Pharmacology & Pharmacy

Surface modification with cholesteryl acetyl carnitine, a novel cationic agent, elevates cancer cell uptake of the PEGylated liposomes

Fahimeh Zahednezhad et al.

Summary: The study successfully synthesized CAC and surface-modified PEGylated liposomes to enhance cancer cell uptake. The CAC + PEG-modified liposomes showed the best cellular uptake and low cytotoxicity at commonly applied concentrations. The results suggest that the organic cation transporter, cationic structure, and metabolic preference of CAC may contribute to the increased cellular uptake in cancer cells.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)

Article Pharmacology & Pharmacy

Peptide-conjugated liposomes for targeted miR-34a delivery to suppress breast cancer and cancer stem-like population

Faezeh Vakhshiteh et al.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2020)

Article Pharmacology & Pharmacy

Scalable solvent-free production of liposomes

Swapnil Khadke et al.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2020)

Review Chemistry, Multidisciplinary

Liposome and immune system interplay: Challenges and potentials

Fahimeh Zahednezhad et al.

JOURNAL OF CONTROLLED RELEASE (2019)

Article Pharmacology & Pharmacy

Critical process parameters in manufacturing of liposomal formulations of amphotericin B

Benjamin Rivnay et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)

Article Pharmacology & Pharmacy

Long chain fatty acid conjugation remarkably decreases the aggregation induced toxicity of Amphotericin B

Kaushik Thanki et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)

Article Chemistry, Multidisciplinary

In vivo protein corona patterns of lipid nanoparticles

A. Amici et al.

RSC ADVANCES (2017)

Review Chemistry, Analytical

Analytical techniques for single-liposome characterization

Chaoxiang Chen et al.

ANALYTICAL METHODS (2013)

Article Biotechnology & Applied Microbiology

Simultaneous determination of purity and potency of amphotericin B by HPLC

Yan Chang et al.

JOURNAL OF ANTIBIOTICS (2011)

Article Cell Biology

Development of a liposomal nanodelivery system for nevirapine

Lakshmi N. Ramana et al.

JOURNAL OF BIOMEDICAL SCIENCE (2010)

Review Chemistry, Medicinal

Amphotericin B formulations and drug targeting

J. J. Torrado et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2008)

Article Microbiology

Comparison of the physicochemical, antifungal, and toxic properties of two liposomal amphotericin B products

Jon A. Olson et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)

Article Pharmacology & Pharmacy

Development of liposomal amphotericin B dry powder inhaler formulation

SP Shah et al.

DRUG DELIVERY (2004)

Article Infectious Diseases

Amphotericin B: spectrum and resistance

D Ellis

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)

Article Chemistry, Analytical

The ICH guidance in practice: stress degradation studies on ornidazole and development of a validated stability-indicating assay

M Bakshi et al.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2001)